|
Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx |
|
|
|
Titel: |
Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx |
Auteur: |
Tsimafeyeu, Ilya Borisov, Pavel Abdelgafur, Ahmed Leonenkov, Roman Novikova, Olga Guseva, Irina Demchenkova, Marina Mikhailova, Nadezhda Semenov, Andrey Yurmazov, Zakhar Sivunova, Irina Ramazanova, Madina Gamayunov, Sergey Kosov, Dmitry Bratslavsky, Gennady |
Verschenen in: |
Targeted oncology |
Paginering: |
Jaargang 14 (2019) nr. 1 pagina's 33-38 |
Jaar: |
2019 |
Inhoud: |
|
Uitgever: |
Springer International Publishing, Cham |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|